Recurrent Myelodysplastic Syndrome Recruiting Phase 1 Trials for Mycophenolate mofetil (DB00688)

Back to Recurrent Myelodysplastic Syndrome
IndicationStatusPhase
DBCOND0113509 (Recurrent Myelodysplastic Syndrome)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04375631
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaTreatment